Tibet Rhodiola Pharmaceutical Holding Co.

¥40.37As of Sun 8 Nov 2026, 12:00 UTC
SSE:600211Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 6.40%
Div yield 4.35%
ROE 22.81%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.24
PE TTM 13.11
TSR TTM (8.37%)
Mkt cap ¥12.85B
ROIC 54.21%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥44
8.35%
0.69%
Hold 8|3|11|8|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.56
0.54
0.53
0.51
23.86%
11.25%
(0.92%)
(10.16%)
Revenue¥B
1.152
1.177
1.222
1.219
9.42%
8.83%
12.43%
10.33%
Peers (US$1.926B)
Cap (US$)
PE
1.907B
—
1.879B
72.96x
Capital
TTM
5Y
10Y
Leveragex
0.338
(0.181)
(0.145)
EBIT/Intx
0.115
0.750
0.734
Own earn%
79.75
27.78
26.93
Sh yield%
43.95
14.12
20.21
Owners
Insiders/Inst%
1.07
77.23
Short interest%
4.44
SBC / revenue%
1.79
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
23–29
$1 testx
—
Incr. ROIC%
4